Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01587495 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics and Safety of Ertapenem in the Postpartum Period
A Phase 1 study, sponsored by Daniel Benjamin.
- Terminated
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT01587495 is a Phase 1 study that was terminated before completion, run by Daniel Benjamin. The registered enrollment target is 3 participants.
The verdict
NCT01587495, a Phase 1 study, was terminated before completion, sponsored by Daniel Benjamin.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The investigators are doing this study to learn more about the dosing and safety of ertapenem in women with suspected serious infections less than 42 days from the delivery of their infant.
Interventions
- DRUG Ertapenem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2012-03 |
| Est. Completion | 2014-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01587495
The ClinicalTrials.gov registry entry for NCT01587495 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Daniel Benjamin, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ertapenem is the first listed.
NCT01587495 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01587495 about?
NCT01587495 is a clinical study titled "Pharmacokinetics and Safety of Ertapenem in the Postpartum Period". The investigators are doing this study to learn more about the dosing and safety of ertapenem in women with suspected serious infections less than 42 days from the delivery of their infant.
What is the current status of trial NCT01587495?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2012-03. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01587495?
The interventions under investigation include: Ertapenem (DRUG).
Who is sponsoring clinical trial NCT01587495?
This trial is sponsored by Daniel Benjamin, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.